- Home
- WNW vs SER Comparison
WNW vs SER Comparison
Compare WNW & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- SER
- Stock Information
- Founded
- WNW 2015
- SER 2017
- Country
- WNW China
- SER United States
- Employees
- WNW N/A
- SER N/A
- Industry
- WNW Catalog/Specialty Distribution
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- SER Health Care
- Exchange
- WNW Nasdaq
- SER Nasdaq
- Market Cap
- WNW 49.2M
- SER 46.7M
- IPO Year
- WNW 2020
- SER 2018
- Fundamental
- Price
- WNW $1.64
- SER $6.42
- Analyst Decision
- WNW
- SER
- Analyst Count
- WNW 0
- SER 0
- Target Price
- WNW N/A
- SER N/A
- AVG Volume (30 Days)
- WNW 355.2K
- SER 31.7K
- Earning Date
- WNW 12-24-2024
- SER 11-12-2024
- Dividend Yield
- WNW N/A
- SER N/A
- EPS Growth
- WNW N/A
- SER N/A
- EPS
- WNW N/A
- SER N/A
- Revenue
- WNW $380,345.00
- SER $3,157,500.00
- Revenue This Year
- WNW N/A
- SER N/A
- Revenue Next Year
- WNW N/A
- SER N/A
- P/E Ratio
- WNW N/A
- SER N/A
- Revenue Growth
- WNW N/A
- SER 2454.55
- 52 Week Low
- WNW $0.71
- SER $3.81
- 52 Week High
- WNW $11.11
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- WNW 75.09
- SER 43.12
- Support Level
- WNW $0.91
- SER $4.15
- Resistance Level
- WNW $1.68
- SER $5.00
- Average True Range (ATR)
- WNW 0.15
- SER 0.61
- MACD
- WNW 0.05
- SER -0.02
- Stochastic Oscillator
- WNW 78.63
- SER 23.21
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.